quinidine has been researched along with Disease Models, Animal in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (36.11) | 18.7374 |
1990's | 9 (12.50) | 18.2507 |
2000's | 18 (25.00) | 29.6817 |
2010's | 15 (20.83) | 24.3611 |
2020's | 4 (5.56) | 2.80 |
Authors | Studies |
---|---|
Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE | 1 |
Chen, X; Chong, CR; Liu, JO; Shi, L; Sullivan, DJ | 1 |
Bajda, M; Brus, B; Czerwińska, P; Filipek, B; Gobec, S; Malawska, B; Sałat, K; Więckowska, A; Więckowski, K | 1 |
Bracke, ME; De Ryck, T; Katritzky, AR; Patronov, A; Roman, BI; Slavov, SH; Stevens, CV; Vanhoecke, BW | 1 |
Aljayyoussi, G; Amewu, RK; Angulo-Barturén, I; Bazaga, SF; Belén, M; Biagini, GA; Campo, B; Charman, SA; Chen, G; Davies, J; Martínez, MS; Nixon, GL; O' Neill, PM; Roberts, NL; Ryan, E; Sabbani, S; Shackleford, DM; Sharma, R; Shore, ER; Stocks, PA; Ward, SA | 1 |
Guo, HF; Jin, J; Li, ZR; Liu, ZY; Xie, ZS; Xue, ST; Yi, H; Zhang, L | 1 |
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Chen, LZ; Huang, X; Liu, MM; Liu, XH; Ma, D; Shi, JB; Shu, HY; Wu, J; Yu, YL | 1 |
Lin, T; Lv, S; Mi, L; Pan, X; Song, J; Tian, F; Wan, Y; Wang, Y; Wu, Z | 1 |
Hamlin, RL; Kijtawornrat, A; Limprasutr, V; Meedech, P; Saengklub, N | 1 |
Behrends, JC; Bode, C; Bodi, I; Brunner, M; Bugger, H; Doleschall, Z; Franke, G; Fürniss, H; Jolivet, G; Lang, CN; Menza, M; Mettke, L; Michaelides, K; Odening, KE; Pantulu, ND; Perez-Feliz, S; Peyronnet, R; Rieke, R; Ryan de Medeiros, A; Steinfurt, J; Zehender, M; Ziupa, D; Zur Hausen, A | 1 |
Antzelevitch, C; Barajas-Martínez, H; Betzenhauser, M; Di Diego, JM; Hu, D; Minoura, Y; Nesterenko, VV; Panama, BK | 1 |
de Lange, EC; Eriksson, J; Koepp, M; Labots, M; Lammertsma, AA; Potschka, H; Rongen, M; Russmann, V; Schuit, R; Seeger, N; Syvänen, S; van Kooij, R; Verbeek, J; Voskuyl, RA; Windhorst, AD; Zellinger, C | 1 |
Antzelevitch, C; Gurabi, Z; Koncz, I; Nesterenko, VV; Patocskai, B | 1 |
Gigout, S; Louvel, J; Pumain, R | 1 |
Albrecht, M; Dombrowsky, H; Frerichs, I; Goldmann, T; Lautenschläger, I; Sarau, J; Uhlig, S; Weiler, N; Zitta, K | 1 |
Matsumoto, RR; Nguyen, L | 1 |
Antzelevitch, C; Belardinelli, L; Guo, D; Hackett, J; Jiao, Z; Li, H; Shryock, JC; Wu, L; Yan, GX | 1 |
Dautova, Y; Grace, AA; Huang, CL; Sabir, I; Zhang, Y | 1 |
Jacobson, G; Sleigh, JW; Steyn-Ross, A; Steyn-Ross, M; Voss, LJ | 1 |
Antzelevitch, C; Burashnikov, A; Nof, E | 1 |
Lazzara, R | 1 |
Dautova, Y; Grace, AA; Huang, CL; Zhang, Y | 1 |
Lacroix, P | 1 |
Dong, QX; Gao, JM; He, JH; Huang, CJ; Li, CQ; Xu, YQ; Xuan, YX; Yu, HP; Zhu, JJ | 1 |
Dukes-Mcewan, J | 1 |
Bauskin, A; Breit, S; Bursill, J; Campbell, T; Singarayar, S; Vandenberg, J; Wu, W; Wyse, K | 1 |
Brooks, BR; Smith, RA | 1 |
Abe, J; Hamada, Y; Harada, T; Hashimoto, K; Horii, I; Sawada, Y; Shiotani, M | 1 |
Lirussi, F; Pussard, E | 1 |
Colledge, WH; Goddard, CA; Grace, AA; Huang, CL; Stokoe, KS; Thomas, G | 1 |
Morita, H; Morita, ST; Wu, J; Zipes, DP | 1 |
Balasubramaniam, R; Colledge, WH; Goddard, CA; Grace, AA; Huang, CL; Stokoe, KS | 1 |
Borggrefe, M; Breithardt, G; Eckardt, L; Milberg, P; Osada, N; Schimpf, R; Tegelkamp, R; Wolpert, C | 1 |
Kaufman, ES | 1 |
Goddard, CA; Grace, AA; Huang, CL; Jones, VJ; Li, LM; Sabir, IN | 1 |
Inoue, H; Mashima, S; Matsuo, H; Murao, S | 1 |
Banitt, EH; Kvam, DC; Schmid, JR | 1 |
Carlson, GP; Fossa, AA | 1 |
Bergey, JL; McCallum, JD; Nocella, K | 1 |
Hernández, J; Serrano, JS | 1 |
Haruna, M; Kimoto, S; Nakao, T; Ueda, M | 1 |
Huang, JD; Leu, BL | 1 |
Gautam, CS; Pandhi, P; Sharma, PL | 1 |
Cha, Y; Feld, GK; Sawhney, N; Shahrokni, S; Wales, A; Wolf, P | 1 |
Cheymol, G; Chézalviel-Guilbert, F; Davy, JM; Deplanne, V; Poirier, JM; Weissenburger, J; Xia, YZ | 1 |
Allessie, MA; Dorland, R; Wijffels, MC | 1 |
Imai, R; Tamura, T; Yamamoto, K; Yamamoto, M | 1 |
Hsiao, CL; Huang, JD; Kan, WM; Kuo, JH; Liu, YT; Shieh, CY; Su, SF | 1 |
Buntenkötter, S | 1 |
Elharrar, V; Gaum, WE; Zipes, DP | 1 |
Billingham, M; Binetti, G; Harrison, DC; Kernoff, R; Markiewicz, W | 1 |
Butterfield, JL; D'Alonzo, AJ; Drexler, AP; Sergio, SL | 1 |
Isaksson, M; Ljunggren, B | 1 |
Bertilsson, L; Kaneko, S; Otani, K | 1 |
Boyden, P; Danilo, P; Leichter, D; Rosen, MR; Rosen, TS | 1 |
Coker, SJ | 1 |
Balazs, T; Ehrreich, SJ; el-Hage, AN; Johnson, GL | 1 |
Inoue, H; Mashima, S; Matsuo, H; Murao, S; Sugimoto, T | 1 |
Inoue, H; Mashima, S; Matsuo, H; Nozaki, A; Sugimoto, T; Toda, I | 1 |
Inoue, H; Matsuo, H; Nozaki, A; Sugimoto, T; Toda, I | 1 |
Kaverina, NV; Senova, ZP; Ul'iànova, OV; Vikxliàev, IuI | 1 |
Faust, G; Fiedler, W | 1 |
Clark, WW; Pearson, RD; Stebbins, WC; Weiland, NG | 1 |
Marmo, E | 1 |
Gorodinskaia, VIa | 1 |
Bhargava, KP; Kohli, RP; Shamsi, MA; Sinha, JN | 1 |
Okuma, M | 1 |
Vrbovský, L | 2 |
Damato, AN; Paulay, KL; Weisfogel, GM | 1 |
Baum, T; Eckfeld, DK; Rowles, G; Shropshire, AT; Varner, LL | 1 |
4 review(s) available for quinidine and Disease Models, Animal
Article | Year |
---|---|
Quinidine in short QT syndrome: an old drug for a new disease.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Electrocardiography; Electrophysiologic Techniques, Cardiac; Flecainide; Genetic Predisposition to Disease; Humans; Quinidine; Rabbits; Sotalol; Treatment Outcome | 2007 |
[Compounds with antiarrhythmic effects].
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Animals, Laboratory; Anti-Arrhythmia Agents; Antidepressive Agents; Antimalarials; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Disease Models, Animal; Histamine H1 Antagonists; Lidocaine; Procainamide; Quinidine; Structure-Activity Relationship | 1973 |
[Combined effect of beta-adrenoblockaders with other pharmacologic agents (review of the literature)].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia, Inhalation; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atropine; Cardiac Glycosides; Cardiovascular Diseases; Disease Models, Animal; Diuretics; Drug Synergism; Ethyl Ethers; Halothane; Heart Failure; Humans; Parasympatholytics; Phentolamine; Pheochromocytoma; Potassium Chloride; Quinidine; Sympatholytics; Vasodilator Agents | 1971 |
[Thrombopenia].
Topics: Animals; Antibodies; Blood Platelets; Disease Models, Animal; Dogs; Freund's Adjuvant; Guinea Pigs; Methods; Phospholipids; Quinidine; Rabbits; Rats; Thrombocytopenia | 1972 |
68 other study(ies) available for quinidine and Disease Models, Animal
Article | Year |
---|---|
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship | 1993 |
A clinical drug library screen identifies astemizole as an antimalarial agent.
Topics: Animals; Antimalarials; Astemizole; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance; Drug Resistance, Multiple; Humans; Mice; Plasmodium falciparum; Plasmodium yoelii | 2006 |
Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo.
Topics: Acetylcholinesterase; Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Humans; Indans; Indoles; Male; Memory; Mice; Models, Molecular; Neuroprotective Agents; Phthalimides; Piperidines; Protein Aggregates; Scopolamine; Structure-Activity Relationship | 2015 |
4-Fluoro-3',4',5'-trimethoxychalcone as a new anti-invasive agent. From discovery to initial validation in an in vivo metastasis model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Products; Cell Line, Tumor; Cell Movement; Cell Survival; Chalcones; Chick Embryo; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Female; Humans; Mice; Mice, Nude; Molecular Structure; Myocardium; Neoplasm Invasiveness; Neoplasm Metastasis; Quantitative Structure-Activity Relationship | 2015 |
Synthesis and profiling of benzylmorpholine 1,2,4,5-tetraoxane analogue N205: Towards tetraoxane scaffolds with potential for single dose cure of malaria.
Topics: Administration, Oral; Animals; Antimalarials; Disease Models, Animal; Drug Stability; Humans; Inhibitory Concentration 50; Malaria; Mice; Morpholines; Plasmodium falciparum; Rats; Tetraoxanes | 2018 |
Substituted benzothiophene and benzofuran derivatives as a novel class of bone morphogenetic Protein-2 upregulators: Synthesis, anti-osteoporosis efficacies in ovariectomized rats and a zebrafish model, and ADME properties.
Topics: Animals; Benzofurans; Bone Morphogenetic Protein 2; Caco-2 Cells; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Inbred BALB C; Molecular Structure; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiophenes; Zebrafish | 2020 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis.
Topics: Administration, Oral; Animals; Arthritis; Cells, Cultured; Dimerization; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Development; Enzyme Inhibitors; Freund's Adjuvant; Humans; Lipopolysaccharides; Male; Mice; Molecular Structure; Nitric Oxide; Nitric Oxide Synthase Type II; Pyrazoles; Pyrimidines; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Structure-Activity Relationship | 2021 |
Downregulating Gasdermin D Reduces Severe Acute Pancreatitis Associated with Pyroptosis.
Topics: Acute Disease; Animals; Disease Models, Animal; Interleukin-18; Intestinal Mucosa; Intestines; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Pancreas; Pancreatitis; Phosphate-Binding Proteins; Pyroptosis; Quinidine; Tumor Necrosis Factor-alpha | 2021 |
Characteristics of electromechanical window in anesthetized rabbit models of short QT and long QT syndromes.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Benzopyrans; Biomarkers; Biomarkers, Pharmacological; Cromakalim; Disease Models, Animal; Electrocardiography; Isoflurane; Long QT Syndrome; Phenethylamines; Pinacidil; Quinidine; Rabbits; Risk; Sulfonamides; Systole; Torsades de Pointes; Ventricular Pressure | 2017 |
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility.
Topics: Action Potentials; Animals; Animals, Genetically Modified; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Electrocardiography; Female; Heart Atria; Heart Conduction System; Heart Defects, Congenital; Heart Ventricles; Humans; Male; Phenotype; Quinidine; Rabbits | 2019 |
Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Brugada Syndrome; Disease Models, Animal; Dogs; Drugs, Chinese Herbal; Myocytes, Cardiac; Patch-Clamp Techniques; Quinidine | 2013 |
[11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Carbon Radioisotopes; Chronic Disease; Disease Models, Animal; Epilepsy; Female; Gene Expression Regulation; Kinetics; Male; Phenobarbital; Positron-Emission Tomography; Quinidine; Quinolines; Radiochemistry; Rats; Rats, Sprague-Dawley; Recurrence; Treatment Outcome | 2013 |
Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cilostazol; Disease Models, Animal; Dogs; Electrocardiography; Heart Conduction System; Hypothermia, Induced; Milrinone; Perfusion; Phosphodiesterase 3 Inhibitors; Quinidine; Signal Transduction; Tachycardia, Ventricular; Tetrazoles; Time Factors; Ventricular Fibrillation | 2014 |
Decrease of neocortical paired-pulse depression in GAERS and possible implication of gap junctions.
Topics: Animals; Anticonvulsants; Carbenoxolone; Cerebral Cortex; Disease Models, Animal; Electric Stimulation; Epilepsy, Absence; Gap Junctions; In Vitro Techniques; Neocortex; Quinidine; Rats, Wistar; Species Specificity; Synaptic Transmission | 2015 |
Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis.
Topics: Animals; Dexamethasone; Disease Models, Animal; Edema; Eicosanoids; Female; Gastrointestinal Diseases; Intestinal Mucosa; Paralysis; Platelet Activating Factor; Protective Agents; Quinidine; Rats; Vasoconstriction | 2015 |
Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Depressive Disorder; Dextromethorphan; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hindlimb Suspension; Imipramine; Ketamine; Male; Mice; Quinidine; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Swimming | 2015 |
Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Ventricles; Myocytes, Cardiac; Quinidine; Rabbits; Sodium; Sodium Channels; Torsades de Pointes | 2008 |
Atrial arrhythmogenesis in wild-type and Scn5a+/delta murine hearts modelling LQT3 syndrome.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Flecainide; Heart Rate; Humans; Long QT Syndrome; Mice; Mice, Transgenic; NAV1.5 Voltage-Gated Sodium Channel; Quinidine; Sodium Channels; Treatment Outcome | 2009 |
Excitatory effects of gap junction blockers on cerebral cortex seizure-like activity in rats and mice.
Topics: Analgesics, Non-Narcotic; Animals; Carbenoxolone; Cerebral Cortex; Connexins; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Enzyme Inhibitors; Female; Gap Junction delta-2 Protein; In Vitro Techniques; Magnesium; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Quinidine; Quinine; Rats; Rats, Sprague-Dawley; Seizures; Time Factors | 2009 |
Cellular basis for atrial fibrillation in an experimental model of short QT1: implications for a pharmacological approach to therapy.
Topics: Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Chlorobenzenes; Disease Models, Animal; Dogs; Electrocardiography; Isoproterenol; Lidocaine; ortho-Aminobenzoates; Quinidine | 2010 |
How the heart can fibrillate: when diversity is a disadvantage.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Chlorobenzenes; Disease Models, Animal; Dogs; Humans; Lidocaine; ortho-Aminobenzoates; Quinidine | 2010 |
Atrial arrhythmogenic properties in wild-type and Scn5a+/- murine hearts.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Function; Brugada Syndrome; Cardiac Pacing, Artificial; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Flecainide; Heart Atria; Heart Ventricles; Mice; Mice, 129 Strain; Mice, Transgenic; NAV1.5 Voltage-Gated Sodium Channel; Perfusion; Quinidine; Sodium Channels; Time Factors; Ventricular Function | 2010 |
Electrocardiographic toxicity in the guinea pig.
Topics: Amitriptyline; Anesthesia; Animals; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Guinea Pigs; Heart Arrest; Male; Papaverine; Quinidine; Specimen Handling | 2002 |
Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Cardiotoxins; Clomipramine; Cyclophosphamide; Disease Models, Animal; Edema; Gentamicins; Heart Diseases; Heart Rate; Heart Ventricles; Larva; Microinjections; Nimodipine; Pericardium; Quinidine; Terfenadine; Tetracycline; Toxicity Tests; Verapamil; Yolk Sac; Zebrafish | 2014 |
Atrial fibrillation: onset and perpetuation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Horse Diseases; Horses; Humans; Prevalence; Quinidine | 2002 |
Extracellular acidosis modulates drug block of Kv4.3 currents by flecainide and quinidine.
Topics: Acidosis; Animals; Anti-Arrhythmia Agents; Biological Transport, Active; Cricetinae; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophysiology; Female; Flecainide; Hydrogen-Ion Concentration; Ion Channel Gating; Membrane Potentials; Models, Cardiovascular; Ovary; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Sensitivity and Specificity; Shal Potassium Channels; Statistics as Topic; Time Factors | 2003 |
Treatment of pseudobulbar affect in ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Brain Chemistry; Dextromethorphan; Disease Models, Animal; Drug Combinations; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Pseudobulbar Palsy; Quinidine; Serotonin | 2005 |
Practical application of guinea pig telemetry system for QT evaluation.
Topics: Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Bepridil; Cisapride; Disease Models, Animal; Electrocardiography; Guinea Pigs; Haloperidol; Heart; Humans; Injections, Intravenous; Long QT Syndrome; Male; Nifedipine; Pimozide; Piperidines; Pyridines; Quinidine; Reproducibility of Results; Telemetry; Terfenadine; Thioridazine | 2005 |
Quinine distribution in pregnant mice with Plasmodium berghei malaria.
Topics: Animals; Antimalarials; Disease Models, Animal; Female; Fetus; Malaria; Mice; Placenta; Plasmodium berghei; Pregnancy; Pregnancy Complications, Parasitic; Quinidine | 2006 |
Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/Delta murine hearts modelling long QT syndrome 3.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Electric Stimulation; Electrocardiography; Electrophysiology; Female; Flecainide; Heart; Heart Conduction System; In Vitro Techniques; Long QT Syndrome; Male; Mice; Mice, Transgenic; NAV1.5 Voltage-Gated Sodium Channel; Quinidine; Sodium Channels | 2007 |
Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Brugada Syndrome; Disease Models, Animal; Dogs; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Conduction System; Heart Ventricles; Male; Pinacidil; Quinidine; Ventricular Fibrillation; Ventricular Function, Right | 2007 |
Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Brugada Syndrome; Disease Models, Animal; Electric Stimulation; Electrophysiology; Female; Flecainide; Gene Expression Regulation; Heart; Male; Mice; Mice, Inbred Strains; NAV1.5 Voltage-Gated Sodium Channel; Quinidine; Sodium Channels | 2007 |
Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Flecainide; Heart Conduction System; In Vitro Techniques; Pinacidil; Quinidine; Rabbits; Random Allocation; Refractory Period, Electrophysiological; Sotalol; Vasodilator Agents | 2007 |
Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Brugada Syndrome; Cardiac Pacing, Artificial; Disease Models, Animal; Electrocardiography; Endocardium; Flecainide; Heart Rate; Long QT Syndrome; Mice; Mice, Transgenic; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Perfusion; Pericardium; Quinidine; Sodium Channels; Time Factors | 2008 |
Effects of atrial pacing, isoprenaline and lignocaine on experimental polymorphous ventricular tachycardia.
Topics: Animals; Blood Pressure; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Electrocardiography; Female; Heart Atria; Heart Rate; Heart Ventricles; Isoproterenol; Lidocaine; Male; Quinidine; Tachycardia | 1984 |
Antiarrhythmic and electrophysiologic actions of flecainide in animal models.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Electrophysiology; Flecainide; Heart Conduction System; In Vitro Techniques; Lidocaine; Piperidines; Procainamide; Quinidine; Rabbits | 1984 |
Antiarrhythmic effect of disulfiram in various cardiotoxic models.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Disulfiram; Heart Diseases; Male; Myocardial Contraction; Ouabain; Quinidine; Rabbits; Rats; Rats, Inbred Strains | 1983 |
Acute coronary artery occlusion-reperfusion-induced arrhythmias in rats, dogs and pigs: antiarrhythmic evaluation of quinidine, procainamide and lidocaine.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Disease Models, Animal; Dogs; Female; Heart Rate; Lidocaine; Male; Perfusion; Potassium; Procainamide; Quinidine; Rats; Rats, Inbred Strains; Species Specificity; Swine | 1982 |
Experimental automaticity induced by mechanical lesion in rat isolated right ventricle: the effects of quinidine, phenytoin, and propranolol.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Female; Male; Phenytoin; Propranolol; Quinidine; Rats; Rats, Inbred Strains; Ventricular Function | 1982 |
[Effects of antiarrhythmic agents on ventricular arrhythmias following myocardial infarct induced with glass beads in dogs (author's transl)].
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Coronary Vessels; Disease Models, Animal; Dogs; Electrocardiography; Female; Glass; Injections, Intra-Arterial; Lidocaine; Male; Myocardial Infarction; Propranolol; Quinidine | 1981 |
Inhibition of intestinal P-glycoprotein and effects on etoposide absorption.
Topics: Adenylyl Imidodiphosphate; Animals; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Etoposide; In Vitro Techniques; Infusions, Intravenous; Intestinal Absorption; Intestine, Small; Jejunum; Male; Microvilli; Quinidine; Rats; Rats, Sprague-Dawley | 1995 |
Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
Topics: Animals; Anti-Arrhythmia Agents; Coronary Disease; Disease Models, Animal; Dogs; Female; Ligation; Male; Propranolol; Quinidine; Sotalol; Tachycardia, Ventricular; Verapamil | 1995 |
Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Flutter; Disease Models, Animal; Dogs; Electrocardiography; Heart Conduction System; Phenethylamines; Quinidine; Sulfonamides; Treatment Outcome | 1996 |
Combination of sotalol and quinidine in a canine model of torsades de pointes: no increase in the QT-related proarrhythmic action of sotalol.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Drug Therapy, Combination; Electrophysiology; Infusions, Intravenous; Quinidine; Sodium Chloride; Sotalol; Torsades de Pointes | 1998 |
Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Disease Models, Animal; Electrocardiography; Flecainide; Follow-Up Studies; Goats; Heart Conduction System; Imidazoles; Injections, Intravenous; Quinidine; Secondary Prevention; Sotalol; Treatment Outcome | 1999 |
Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation-influences of anesthesia and validation with quinidine and astemizole.
Topics: Acute Disease; Anesthesia; Anesthetics, Inhalation; Animals; Astemizole; Atrioventricular Node; Catheter Ablation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electric Stimulation; Electrocardiography; Female; Halothane; Heart Block; Isoflurane; Long QT Syndrome; Male; Pentobarbital; Quinidine; Sensitivity and Specificity; Torsades de Pointes | 2001 |
Effect of hydroxyzine on the transport of etoposide in rat small intestine.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Etoposide; Histamine H1 Antagonists; Hydroxyzine; In Vitro Techniques; Infusions, Intravenous; Intestinal Absorption; Intestine, Small; Jejunum; Male; Microvilli; Quinidine; Rats; Rats, Sprague-Dawley; Time Factors | 2001 |
[Myocardial model arrhythmias and anti-arrhythmic principles].
Topics: Animals; Animals, Laboratory; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Membrane Permeability; Disease Models, Animal; Drug Evaluation, Preclinical; Quinidine; Stimulation, Chemical; Swine | 1978 |
Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs.
Topics: Animals; Aprindine; Arrhythmias, Cardiac; Coronary Disease; Disease Models, Animal; Dogs; Heart Conduction System; Indenes; Isoproterenol; Quinidine; Verapamil | 1977 |
Problems in assessing infarction size by epicardial mapping: preliminary studies with quinidine.
Topics: Animals; Disease Models, Animal; Dogs; Electrocardiography; Hemodynamics; Myocardial Infarction; Myocardium; Quinidine | 1976 |
Comparison of the effects of intravenous LNC-834, a new antiarrhythmic agent, and quinidine in canine models of arrhythmia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Female; Hemodynamics; Hypotension; Male; Quinidine; Ventricular Fibrillation | 1990 |
Ultraviolet B irradiation inhibits the induction of photoallergy to systemically administered quinidine in the mouse.
Topics: Animals; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Radiation; Female; Inflammation; Injections, Intraperitoneal; Mice; Photosensitivity Disorders; Quinidine; Skin; Ultraviolet Rays | 1991 |
Studies on active transport of (E)-10-hydroxynortriptyline in the kidney and brain of rats: effects of propranolol and quinidine.
Topics: Animals; Biological Transport, Active; Brain; Disease Models, Animal; Kidney; Male; Metabolic Clearance Rate; Nortriptyline; Propranolol; Quinidine; Rats; Rats, Inbred Strains | 1991 |
A canine model of torsades de pointes.
Topics: Aconitine; Aconitum; Animals; Disease Models, Animal; Dogs; Electrocardiography; Electrodes, Implanted; Heart; Quinidine; Tachycardia | 1988 |
Anesthetized rabbit as a model for ischemia- and reperfusion-induced arrhythmias: effects of quinidine and bretylium.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Bretylium Compounds; Coronary Disease; Coronary Vessels; Disease Models, Animal; Male; Myocardial Reperfusion; Myocardial Reperfusion Injury; Quinidine; Rabbits | 1989 |
Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death.
Topics: Animals; Anti-Arrhythmia Agents; Body Weight; Bretylium Tosylate; Death, Sudden; Disease Models, Animal; Electrocardiography; Isoproterenol; Male; Niacin; Phenytoin; Procainamide; Propranolol; Quaternary Ammonium Compounds; Quinidine; Rats; Ventricular Fibrillation; Verapamil | 1986 |
Ventricular fibrillation threshold in canine hearts with quinidine induced prolonged QT interval: effects of atrial pacing, isoproterenol, and lignocaine.
Topics: Animals; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Female; Heart; Isoproterenol; Lidocaine; Male; Quinidine; Tachycardia; Ventricular Fibrillation | 1986 |
Inhomogeneity of ventricular refractory period in canine heart with quinidine-induced long QT interval: a comparative study on effects of heart rate, isoprenaline, and lignocaine.
Topics: Animals; Disease Models, Animal; Dogs; Electric Stimulation; Female; Heart; Heart Rate; Isoproterenol; Lidocaine; Male; Quinidine; Tachycardia | 1985 |
Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval.
Topics: Animals; Blood Pressure; Bretylium Compounds; Bretylium Tosylate; Disease Models, Animal; Dogs; Female; Heart; Male; Quinidine; Tachycardia; Ventricular Fibrillation | 1985 |
[Antiarrhythimic properties of ethmozine].
Topics: Aconitum; Animals; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Cats; Coronary Vessels; Depression, Chemical; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Heart Rate; Humans; Ligation; Procainamide; Quinidine; Rats; Stimulation, Chemical; Tachycardia, Paroxysmal; Time Factors | 1970 |
Noise-and drug-induced hearing loss in monkeys.
Topics: Acoustic Stimulation; Animals; Auditory Threshold; Conditioning, Operant; Deafness; Disease Models, Animal; Haplorhini; Hearing Loss, Noise-Induced; Kanamycin; Macaca; Methods; Neomycin; Papio; Quinidine; Sodium Salicylate; Time Factors | 1973 |
Effects of different drugs with beta-adrenolytic activity on experimental models of arrhythmias.
Topics: Aconitum; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Asphyxia; Barium; Calcium Chloride; Cats; Chlorides; Chloroform; Disease Models, Animal; Electrocardiography; Epinephrine; Guinea Pigs; Magnesium; Male; Potassium; Quinidine; Rats; Sodium Chloride; Strophanthins; Sympatholytics; Vasopressins | 1971 |
Centrogenic cardiac arrhythmia induced by aconitine: a new "model" for screening of anti-arrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Alkaloids; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Coronary Vessels; Disease Models, Animal; Dogs; Electrocardiography; Epinephrine; Female; Ligation; Male; Phenytoin; Procainamide; Propranolol; Quinidine | 1971 |
[Comparison of the effect of various antiarrhythmic drugs on the model of experimental epinephrine arrhythmia].
Topics: Amides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Disease Models, Animal; Dogs; Epinephrine; Ethylamines; Female; Male; Phenanthrenes; Procainamide; Quinidine | 1973 |
Sinus nodal reentry. Effect of quinidine.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Disease Models, Animal; Dogs; Electrocardiography; Heart Conduction System; Pacemaker, Artificial; Quinidine; Tachycardia | 1974 |
Observations on models used for the evaluation of antiarrhythmic drugs.
Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atropine; Benzazepines; Bretylium Compounds; Chlorpheniramine; Diazepam; Disease Models, Animal; Dogs; Drug Antagonism; Guinea Pigs; Imipramine; Ketones; Lidocaine; Male; Meperidine; Mephentermine; Ouabain; Phentolamine; Phenytoin; Procainamide; Promazine; Promethazine; Propranolol; Quinidine | 1971 |
[Relative effectiveness of various antiarrhythmia drugs in experimental aconitine arrhythmia].
Topics: Aconitum; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Disease Models, Animal; Dogs; Female; Male; Procainamide; Quinidine | 1971 |